The process of gathering information, verifying facts and assessing risks associated with a business transaction is called “due diligence”. A key challenge in any due diligence is how to gather, verify and evaluate this information within the time and budgetary constraints of the transaction.
Prior to embarking on any due diligence with an intellectual property (IP) component, it is useful if not imperative to understand the following:
- What is the nature of the transaction? Is it a license agreement, an acquisition, a merger, an investment or an IPO?
- Is there specific technology considered key to the deal? Is access to specific technology or a product line driving this deal?
- With respect to any key technology, where is it on the patent life cycle? Has it been patented? Is it an FDA approved product ? Is access to manufacturing key to the deal?
- Is the owner of the technology a publicly-traded company subject to the Sarbanes-Oxley Act of 2002?
- Is the market for the technology domestic or foreign, or both?
Read the complete article by clicking on the link below.
Author(s)
Related Insights
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.
June 4, 2025
Energy Current
Nuclear’s Comeback: What Renewables Professionals Should Know
The clean energy transition isn’t a zero-sum game – it’s a team effort. And one player is stepping back into the spotlight with renewed…
June 4, 2025
Foley Ignite
M&A Disputes Set to Rise in Latin America: How Savvy Investors Are Protecting Themselves
As deal activity shows signs of rebounding in 2025, investors are bracing for an increase in M&A-related disputes globally, and Latin…